CURTIS STENNETT: Open Payments
NPI 1831432574 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 15 payments from 9 companies in 2025. Trend: 2023 $376 · 2024 $207 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $46 |
| Lundbeck LLC | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Corium, LLC | 1 | $14 |
Products named: COBENFY, SPRAVATO, TRINTELLIX, REXULTI, Jornay PM, Auvelity, Qelbree, Azstarys.
Industry payments across IN — which companies pay providers there.
